UC Davis cancer researchers have discovered significant differences in radiation-therapy response among patients with oropharyngeal cancer depending on whether they carry the human papillomavirus (HPV), a common sexually transmitted virus. The findings could lead to more individualized radiation treatment regimens, which for many patients with HPV could be shorter and potentially less toxic. Read more here.
Study mentioned: Chen AM, et al. Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer. Laryngoscope. 2012 Sep 24. [Epub ahead of print] PMID: 23008061
No comments:
Post a Comment